What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Parkinson's disease
- Neuroscience
Andreas Kupsch focuses on Neuroscience, Parkinson's disease, Subthalamic nucleus, Deep brain stimulation and Basal ganglia.
His work on Local field potential, Dopamine, Supplementary motor area and Connectome as part of general Neuroscience research is frequently linked to Chemistry, bridging the gap between disciplines.
His Parkinson's disease research is multidisciplinary, relying on both Central nervous system disease and Parkinsonism.
His Subthalamic nucleus research incorporates elements of Human Connectome, Resting state fMRI, Primary motor cortex, Cortical Synchronization and Cohort.
Andreas Kupsch has researched Deep brain stimulation in several fields, including Audiology, Dystonia, Psychiatry, Randomized controlled trial and Stroop effect.
His Basal ganglia research is multidisciplinary, incorporating perspectives in Beta Rhythm, Electroencephalography, Stimulation and Premovement neuronal activity.
His most cited work include:
- A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease (1930 citations)
- Neurostimulation for Parkinson's Disease with Early Motor Complications (780 citations)
- Pallidal Deep-Brain Stimulation in Primary Generalized or Segmental Dystonia (702 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Neuroscience, Deep brain stimulation, Subthalamic nucleus, Parkinson's disease and Dystonia.
Andreas Kupsch combines subjects such as Physical medicine and rehabilitation, Movement disorders, Stimulation, Neurostimulation and Neurology with his study of Deep brain stimulation.
In his study, which falls under the umbrella issue of Neurostimulation, Quality of life is strongly linked to Randomized controlled trial.
By researching both Subthalamic nucleus and Chemistry, Andreas Kupsch produces research that crosses academic boundaries.
His study in Parkinson's disease is interdisciplinary in nature, drawing from both Physical therapy and Central nervous system disease.
As a member of one scientific family, he mostly works in the field of Dystonia, focusing on Anesthesia and, on occasion, Adverse effect, Surgery and Dyskinesia.
He most often published in these fields:
- Neuroscience (49.29%)
- Deep brain stimulation (36.52%)
- Subthalamic nucleus (28.01%)
What were the highlights of his more recent work (between 2012-2021)?
- Deep brain stimulation (36.52%)
- Neuroscience (49.29%)
- Dystonia (21.63%)
In recent papers he was focusing on the following fields of study:
Andreas Kupsch focuses on Deep brain stimulation, Neuroscience, Dystonia, Anesthesia and Parkinson's disease.
His Deep brain stimulation research includes themes of Physical medicine and rehabilitation, Neurology, Quality of life, Stimulation and Movement disorders.
In Neuroscience, Andreas Kupsch works on issues like Subthalamic nucleus, which are connected to Primary motor cortex.
The study incorporates disciplines such as Adverse effect, Surgery, Cohort and Myoclonus in addition to Dystonia.
The Anesthesia study combines topics in areas such as Cerebral autoregulation, Gene mutation and Neurostimulation.
His Parkinson's disease study incorporates themes from Dopamine and Guillain-Barre syndrome.
Between 2012 and 2021, his most popular works were:
- Neurostimulation for Parkinson's Disease with Early Motor Complications (780 citations)
- Connectivity Predicts deep brain stimulation outcome in Parkinson disease. (226 citations)
- Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial (175 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Parkinson's disease
- Neuroscience
Andreas Kupsch mainly focuses on Deep brain stimulation, Dystonia, Anesthesia, Subthalamic nucleus and Neuroscience.
Deep brain stimulation is a subfield of Internal medicine that Andreas Kupsch studies.
He studied Dystonia and Adverse effect that intersect with Botulinum toxin, Dysphagia, Dosing and Clinical significance.
His work investigates the relationship between Anesthesia and topics such as Gene mutation that intersect with problems in Young adult, Genetic testing and Retrospective cohort study.
His Subthalamic nucleus study deals with Quality of life intersecting with Disease and Clinical endpoint.
His Parkinson's disease study integrates concerns from other disciplines, such as Dopaminergic and Dopamine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
